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Abstract
Background: A proposed role for Myc in maintaining mouse embryonic stem (ES) cell pluripotency is
transcriptional repression of key differentiation-promoting genes, but detail of the mechanism has remained an
important open topic.
Results: To test the hypothesis that the zinc finger protein Miz-1 plays a central role, in the present work we
conducted chromatin immunoprecipitation/microarray (ChIP-chip) analysis of Myc and Miz-1 in human ES cells,
finding homeobox (Hox) genes as the most significant functional class of Miz-1 direct targets. Miz-1 differentiation-
associated target genes specifically lack acetylated lysine 9 and trimethylated lysine 4 of histone H3 (AcH3K9 and
H3K4me3) 9 histone marks, consistent with a repressed transcriptional state. Almost 30% of Miz-1 targets are also
bound by Myc and these cobound genes are mostly factors that promote differentiation including Hox genes.
Knockdown of Myc increased expression of differentiation genes directly bound by Myc and Miz-1, while a subset
of the same genes is downregulated by Miz-1 loss-of-function. Myc and Miz-1 proteins interact with each other
and associate with several corepressor factors in ES cells, suggesting a mechanism of repression of differentiation
genes.
Conclusions: Taken together our data indicate that Miz-1 and Myc maintain human ES cell pluripotency by
coordinately suppressing differentiation genes, particularly Hox genes. These data also support a new model of
how Myc and Miz-1 function on chromatin.
Background
Miz-1 is a member of the POZ domain/zinc finger tran-
scription factor family. It contains 13 zinc fingers and a
POZ/BTB (BTB for BR-C, ttk and bab, POZ for Pox
virus and zinc finger) domain at its N-terminus [1]. In
cancer cell lines, Miz-1 binds to specific sequences
termed initiator elements (INR) in the core promoters
of its target genes and activates their transcription
through recruitment of coactivators including the his-
tone acetyltransferase (HAT) p300 and nucleophosmin
[2-4]. Among previously identified Miz-1 regulated tar-
gets are negative regulators of cell cycle control and cell
growth, including p15Ink4b, p21Cip1,a n dc/EBPa
[3,5,6]. By activating negative regulators of cell cycle,
Miz-1 has a growth arrest function. In addition, Miz-1
interacts with Myc and recruits it to the promoters of
its target genes to repress transcription [1]. Miz-1 also
functions with repressor proteins such as Bcl-6, Zbtb4,
and Gfi-1 [7-9]. Upon binding to Myc, transcriptional
activation by Miz-1 is inhibited and Myc/Miz-1 com-
plexes act as transcriptional repressors. Myc represses
transactivation by Miz-1 at least in part by competing
with p300 and nucleophosmin for binding to Miz-1
[3,4]. The Myc/Miz-1 complex also recruits the DNA
methyltransferase, DNA (cytosine-5)-methyltransferase
3A (Dnmt3a), and histone deacetylases (HDACs) to
gene promoters leading to silencing of gene expression
[10,11]. Myc, therefore, overcomes Miz-1-induced
growth arrest by binding to Miz-1 to repress target
genes involved in cell cycle regulation.
Myc genes were initially characterized as proto-onco-
genes and the proteins they encode belong to the family
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[12]. Myc proteins regulate normal proliferation, cell
growth, and apoptosis, cellular functions aberrantly
regulated by excess Myc during malignant transforma-
tion (reviewed in [13]). Myc has the ability to both posi-
tively and negatively regulate transcription. The most
thoroughly studied and understood function of Myc is
its ability to activate genes via binding to specific DNA
sequences called E-boxes with its partner protein, Max
[14-16]. The Myc/Max complex recruits several coacti-
vators and HATs to DNA such as transformation/tran-
scription domain-associated protein (TRRAP), Gcn5 and
Tip60, which leads to promoter activation [17,18].
c-Myc also binds to positive transcription elongation
factor b (p-TEFb) and contributes to pause release in
embryonic stem (ES) cells thus promoting transcrip-
tion from its target genes [19,20]. Myc represses tran-
scription at least in part by targeting Miz-1 with
important biological consequences. For example, Myc
regulates keratinocyte differentiation [21] and enhances
self-renewal of neural progenitor cells (NPCs) [22] via
binding to Miz-1. The Myc/Miz-1 complex in addition
inhibits the differentiation of preadipocytes to adipo-
cytes in culture, a process which is controlled by the
transcription factor CCAAT/enhancer binding protein
alpha (c/EBP-a) [23]. Furthermore, the Myc/Miz-1
complex suppresses the expression of Mad4,w h i c h
plays an important role in the control of cellular pro-
liferation and differentiation in mouse erythroleukemia
(MEL) cells [24].
Myc plays critical roles in maintenance of mouse ES
cell pluripotency and self-renewal, as well as induction
of pluripotency during induced pluripotent stem (iPS)
cell formation [25-29]. Myc maintains and induces pluri-
potency at least in part by repressing differentiation-
associated gene expression, but the molecular mechan-
isms of Myc repression of differentiation genes in stem
cells are yet to be fully defined. Much the same as Myc,
Miz-1 knockout embryos are not viable, suggesting
important, but as yet uncharacterized roles for Miz-1 in
stem cells and early embryogenesis [30]. No unbiased,
global genomic studies have been reported for Miz-1
leaving its transcriptional function less clear than that of
Myc. We hypothesized that Myc and Miz-1 function
coordinately together in ES cells to delineate the expres-
sion of differentiation-associated genes. To test this
hypothesis we conducted functional genomics studies
for Miz-1, focusing on human ES cells and in parallel
characterizing Myc genomic function in the same cells.
Our findings define an important new role for Myc and
Miz-1 in regulating differentiation-related gene expres-
sion, particularly homeobox (Hox) gene expression, in
human ES cells.
Results
Analysis of genome-wide Miz-1 binding in human ES cells
indicates Hox genes as the most common targets
We conducted chromatin immunoprecipitation/microar-
ray (ChIP-chip) analysis to define Miz-1 genomic DNA
binding in human ES cells. For the ChIP-chip analysis
we used the 2.1 M Deluxe promoter array platform
(Roche Nimblegen, Indianapolis, IN) and a well charac-
terized Miz-1-specific antibody [31] from biological
replicates of exponentially growing human ES cells. We
identified 734 genes bound by Miz-1 in both replicate
samples. Regions of Miz-1 binding were functionally
annotated for gene ontology (GO; http://david.abcc.
ncifcrf.gov/), indicating that Miz-1-occupied genes are
involved in embryonic development, differentiation,
chromatin packaging, as well as RNA binding and pro-
tein ubiquitination processes (Figure 1A). Importantly,
the most significant class of Miz-1 direct target genes
was Hox genes (P value = 6E-8) including HOXB2,
HOXB6, VAX2, MEIS1, PAX3, PAX7 and others. Nanog
and POU5F1 were also among Miz-1 target genes [see
Table S1 in Additional file 1 for a comprehensive list of
Miz-1 target genes].
A dichotomous relationship of Miz-1 genomic binding to
histone marks associated with transcriptional activation
To determine if there is an association between Miz-1
binding and actively transcribed euchromatic domains,
in parallel to Miz-1 ChIP-chip, we performed ChIP-chip
analysis in ES cells using antibodies specific to acety-
lated lysine 9 and trimethylated lysine 4 of histone H3
(AcH3K9 and H3K4me3), which are known marks of
transcriptionally active, euchromatic domains. We com-
pared Miz-1 bound target genes to regions of H3K4me3
or AcH3K9 enrichment (Figure 1B; [see Table S1 in
Additional file 1]). Transcriptional activation marks
H3K4me3 and AcH3K9 were found on 553 Miz-1 target
genes, which included genes primarily involved in RNA
binding, cytoskeleton, protein ubiquitination, cell cycle
and regulation of transcription. Nanog and POU5F1,
encoding known pluripotency factors, are Miz-1 bound
and also enriched in AcH3K9 and H3K4me3, consistent
with their active gene expression state in human ES
cells. Importantly, specific individual peaks of H3K4me3
and AcH3K9 overlapped with Miz-1 binding peaks, sug-
gesting a tight association between Miz-1 and these
marks. We also found 181 Miz-1 target genes that were
not associated with H3K4me3 and AcH3K9 marks,
including most prominently Hox genes, but also other
genes involved in development and differentiation.
To determine which of the Miz-1 bound genes are
enriched in the H3K27me3 silencing histone modifica-
tion, we compared genes bound by Miz-1 with genes
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in human ES cells [32]. We found that out of the 181
M i z - 1b o u n dg e n e st h a ta r en o ta s s o c i a t e dw i t h
H3K4me3 and AcH3K9, 45 genes contain H3K27me3
(25%). In contrast, out of 553 Miz-1 bound genes
associated with activation marks only 36 genes have
H3K27me3 (6%) [see Table S1 in Additional file 1].
Examples of such comodified Miz-1 bound genes
include several Hox genes such as MEIS2, PAX6, GSC,
and SHOX2.
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Figure 1 Genomic binding of Miz-1 and functional ontology of its target genes in human embryonic stem (ES) cells. (A) Gene ontology
(GO) functional annotation of Miz-1 bound genes was performed using DAVID functional annotation software. The most significant biological
process GO terms are shown. The number of genes belonging to each category within the Miz-1 bound population is indicated by black bars.
(B) Acetylated lysine 9 and trimethylated lysine 4 of histone H3 (AcH3K9 and H3K4me3) status for Miz-1 bound target genes. P values are
indicated in all cases.
Varlakhanova et al. Epigenetics & Chromatin 2011, 4:20
http://www.epigeneticsandchromatin.com/content/4/1/20
Page 3 of 14Identification of genes bound by c-Myc and N-Myc in
human ES cells
Because Miz-1 is known to bind to Myc, for comparison
we analyzed Myc genomic binding in human ES cells,
focusing on c-Myc and N-Myc, the predominant Myc
proteins expressed in ES cells. Using ChIP-chip analysis,
we identified 3,498 putative direct Myc bound target
genes (c-Myc and/or N-Myc bound) (Figure 2A; [see
Table S2 in Additional file 1]). By comparing Myc target
genes with regions of H3K4me3 or AcH3K9, we found
that most Myc-bound genes (2,319 genes; 66%) are asso-
ciated with active histone modifications [see Table S2 in
Additional file 1]. These putative targets of Myc tran-
scriptional activation encode proteins involved in meta-
bolism, ribosomal biology, apoptosis and signaling
( F i g u r e2 A ) .N o t a b l y ,o u to f3 , 4 9 8M y ct a r g e tg e n e s ,
about one-third (1,179 genes) are not associated with
H3K4me3 and/or AcH3K9 [see Table S2 in Additional
file 1]. Many of the potential targets of Myc repression
encode transcription factors involved in differentiation
such as PAX7, DLL1, DLL3, and numerous Hox genes
(Figure 2A). We further validated a subset of Myc bind-
ing targets identified in our ChIP-chip experiments and
their associated histone mark profiles by employing
direct ChIP assays with c-Myc, N-Myc, AcH3K9 and
H3K4me3 antibodies (Figure 2B), with all those tested
being validated. PR2Y2, which is not bound by either N-
Myc or c-Myc, was used as a negative control for Myc
binding. The relative abundance of AcH3K9 and
H3K4me3, as suggested by the ChIP-chip assays, was
strikingly different in direct ChIP assays at metabolic/
pluripotency genes (high levels) versus differentiation-
associated genes (nearly absent levels; Figure 2B).
Miz-1 and Myc co-occupy the promoters of Hox genes
and other differentiation-associated genes
To determine if Miz-1 and Myc bind and regulate com-
mon sets of genes, we compared Miz-1 target genes
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Figure 2 Genomic binding of Myc and functional ontology of its target genes in human embryonic stem (ES) cells. (A) Acetylated lysine
9 and trimethylated lysine 4 of histone H3 (AcH3K9 and H3K4me3) status for Myc bound genes. Gene ontology analysis for Myc bound genes
with or without enrichment in histone activation marks H3K4me3 and AcH3K9 was performed using DAVID functional annotation software. P
values are indicated. Myc binding events that do not overlap with either histone modification are represented by the blue circle. (B)
Confirmation of Myc direct targets identified by chromatin immunoprecipitation/microarray (ChIP-chip). ChIP was performed using antibodies to
c-Myc, N-Myc, AcH3K9, and H3K4me3. PR2Y2 gene, not bound by either c-Myc or N-Myc, was used as a negative control.
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Page 4 of 14with the genomic targets of Myc. We found very signifi-
cant overlap as 203 genes out of 734 Miz-1 target genes
are co-occupied by Myc (P value = 0) (Figure 3A; [see
Table S3 in Additional file 1]). Miz-1/Myc target genes
included Hox genes and genes involved in neural and
muscle differentiation including HOXB2, PAX3, PAX7,
and VAX2. We further validated a subset of Myc/Miz1
binding targets by direct ChIP analysis with Miz-1 and
N-Myc antibodies (Figure 3B), with all those tested
being validated. SnurpN or OSRF,w h i c ha r eb o u n d
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Figure 3 Myc and Miz-1 are cobound on differentiation-associated genes. (A) Venn diagram showing overlap of Miz-1 and Myc bound
genes. The most significant biological process gene ontology (GO) terms are shown on the right with P values. (B) Chromatin
immunoprecipitation (ChIP) confirmation of Miz-1 and Myc common target genes identified by ChIP/microarray (ChIP-chip) analysis. SnurpN and
OSRF genes, identified to be bound respectively only by Miz-1 or only by N-Myc by ChIP-chip, were used as a negative control.
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Page 5 of 14respectively only by Miz-1 or only by N-Myc based on
our ChIP-chip data, were used as negative control for
N-Myc and Miz-1 binding, respectively. Examples of
ChIP-chip enrichment profiles observed for Myc, Miz-1,
AcH3K9 and H3K4me3 for Myc and Miz1 target genes
are presented in Figure 4A, showing actual peak data.
The majority of differentiation-associated genes bound
by both Myc and Miz-1 exhibit a repressive profile of
low/absent AcH3K9 and H3K4me3. When compared to
the H3K27me3 whole genome binding profile reported
previously [32], 35% of Myc and Miz-1 cobound genes
with low/absent AcH3K9 and H3K4me3 are enriched in
H3K27me3, further demonstrating their repressed state.
Myc/Miz-1 bound differentiation-associated target genes
with low levels of AcH3K9 and H3K4me3 in our ChIP-
chip assays also showed very high relative levels of
H3K27me3 (Figure 4B). In contrast, Myc and Miz-1
cobound genes such as OCT4, PKNOX2 and MYL3 that
also have robust peaks of AcH3K9 and H3K4me3 in
their promoters, suggesting they are actively transcribed,
do not have significant H3K27me3. The metabolic genes
bound by N-Myc but not by Miz-1 are also not marked
by H3K27me3, which fits with their transcriptionally
active state (Figure 4B).
We analyzed the specific regions of Miz-1 and Myc
genomic binding using location analysis (NimbleScan
software, Roche Nimblegen, Indianapolis, IN), annotat-
ing them to the nearest transcriptional start site (TSS;
Figure 4C). Interestingly, we found that the majority of
genomic regions for both Miz-1 and Myc binding (all
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Figure 4 Target genes bound by both Myc and Miz-1 have a distinct, transcriptionally inactive profile of histone marks. (A) Examples
of enrichment profiles observed for Myc, Miz-1, acetylated lysine 9 of histone H3 (AcH3K9) (AcK9) and trimethylated lysine 4 of histone H3
(H3K4me3) (TMK4) for Myc/Miz-1, Miz-1 alone or Myc alone bound genes are shown. Miz-1, Myc, TMK4, and AcK9 are indicated in blue, red,
green, and purple, respectively. Black horizontal arrows indicate direction of transcription. Peaks are on a Log2 scale. Gene names are indicated
above the colored horizontal bars with tiled regions immediately below and transcriptional start sites (TSSs) are indicated by short vertical lines
near the bottom. (B) Chromatin immunoprecipitation (ChIP) analysis of H3K27me3 enrichment on Myc/Miz-1 and Myc alone bound genes. (C)
Myc and Miz-1 binding distribution relative to the TSS.
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Page 6 of 14binding sites, not just cobound sites) are located at least
1 kb upstream of TSSs (Miz-1 is 51%, Myc is 63%),
while the current model of Miz-1 binding, not based on
functional genomics data, suggests that Miz-1 binding
elements (INR) are predominantly localized in the core
TSS region. The binding pattern for Myc that we found,
however, is in agreement with previously reported loca-
tion analysis of Myc binding sites in the human genome
[33]. Supporting the notion of linked Myc and Miz-1
function, in more than half of Myc and Miz-1 cobound
genes (109 out of 203 genes) actual binding loci of Myc
and Miz-1 are in close proximity to one another (peaks
are located within 250 bp of each other), suggesting that
Myc and Miz-1 factors work through shared genomic
domains, and function either within common protein
complexes or within shared, small cis-regulatory ele-
ments [see Table S3 in Additional file 1].
To determine whether the experimentally identified
Myc and Miz-1 cobound sites possess a consensus motif
that might be utilized by the Myc/Miz-1 complex, we
used MEME [34], but no con s e n s u sm o t i fw a sf o u n d
among Miz-1 or Myc/Miz-1 bound sequences. In con-
trast, Myc target loci show a substantial enrichment in
Myc-binding consensus E-box motifs (CACGTG) (P
value = 9.7E-277) when analyzed by Cis-regulatory Ele-
ment Annotation System (CEAS; http://liulab.dfci.har-
vard.edu/CEAS/) [35]. However, no enrichment in E-
box motifs in target loci simultaneously bound by Myc
and Miz-1 was found, which indicates that the binding
of the Myc/Miz-1 complex to its target genes is likely
most often E-box-independent.
Myc knockdown in human ES cells leads to growth arrest
and upregulation of differentiation-associated target
genes
We hypothesized that by disrupting Myc expression in
human ES cells, repression by the Myc/Miz-1 complexes
would be relieved leading in turn to the upregulation of
differentiation-associated target gene expression. To test
this idea and to evaluate the effect of Myc loss-of-function
on global gene expression changes in human ES cells, we
employed lentiviral vectors to introduce small hairpin (sh)
RNAs designed to specifically knockdown (KD) either
endogenous c-Myc or N-Myc. We observed approximately
60% decreases in c-Myc and N-Myc RNA levels, respec-
tively, 5 days after separate introduction of each shRNA
(Figure 5A). Myc protein levels were more substantially
decreased (threefold to fourfold) upon introduction of the
Myc shRNAs [see Figure S1 in Additional file 2]. Simulta-
neous KD of c-Myc and N-Myc completely inhibited the
formation of viable colonies (not shown). In the context of
both the independent c-Myc KD and the N-Myc KD, 5
days after shRNA introduction, human ES cells exhibited
a significant inhibition of colony growth and size,
accompanied by colony morphological changes character-
istic of spontaneous differentiation (Figure 5B). Consistent
with these changes, alkaline phosphatase (AP) staining, a
marker of undifferentiated ES cells, decreased in c-Myc
and N-Myc KD ES cells relative to control ES cells (Figure
5B).
To further study the effect of Myc loss-of-function on
gene expression, we performed transcriptome analysis
on day 5 Myc knockdown and control H9 human ES
cells. Genes whose expression changed by at least
1.5-fold and that had a P value < 0.05 were considered
differentially expressed. We found that 1,825 genes were
upregulated and 1,060 genes were downregulated in
c-Myc and/or N-Myc KD human ES cells [see Table S4
in Additional file 1]. Approximately 17% of the genes
with changed expression upon Myc KD are Myc direct
targets identified by our ChIP-chip studies. GO analysis
indicated that genes involved in ES cell differentiation,
Wnt signaling and apoptosis were upregulated, whereas
genes important for transcriptional repression, signaling
and negative regulation of differentiation were downre-
gulated (Figure 5C, D). Of particular note, a large num-
ber of Hox genes (36 genes) were upregulated at least
1.5 fold upon disruption of Myc expression, with many
being common genomic binding targets for both Myc
and Miz-1 proteins. Importantly, Myc knockdown led to
an upregulation in expression of approximately 10% of
all Miz-1 direct target genes identified by ChIP-chip
analysis (76 out of 735 genes) with the majority of them
being involved in ES cell differentiation. We validated
our results obtained by microarray analysis through
quantitative real-time qRT-PCR (Figure 6A, B).
To study Myc and Miz-1 occupancy of Hox genes
upon ES cell differentiation, we differentiated human ES
cells into embryoid bodies (EBs). The ChIP analysis of
Myc and Miz-1 binding to Hox genes in ES cells and
EBs demonstrated a drastic reduction in Myc binding to
all Hox genes tested in EBs, whereas Miz-1 binding
remained mostly unchanged or only modestly decreased
[see Figure S2A in Additional file 3]. Differentiation-
associated gene expression was significantly upregulated
in EBs compare to ES cells, as assessed by qRT-PCR
analysis [see Figure S2B, C in Additional file 3].
Evidence of transcriptional antagonism
between Miz-1 and Myc
To measure the effects of Miz-1 KD on gene expression
in human ES cells, we introduced shRNA specific to
human Miz-1. We obtained a significant Miz-1 KD,
which was confirmed by Western blot analysis [see Fig-
ure S3A in Additional file 4]. Miz-1 KD was not asso-
ciated with any clear phenotypic changes in ES cell
colony morphology [see Figure S3B in Additional file 4].
Gene expression array analysis on Miz-1 KD human ES
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Page 7 of 14cells revealed upregulation of 1,232 genes, with 11% of
these genes being direct targets for Miz-1 as identified by
ChIP-chip [see Table S5 in Additional file 1]. These upre-
gulated genes comprised genes regulating mitochondrion
biology, RNA metabolism, and cell cycle. Only 151 genes
were downregulated upon Miz-1 knockdown, but impor-
tantly 16% of these genes were directly bound by Miz-1
and included Hox genes such as MEIS1, HOXB5 and
HOXB8, and some apoptosis regulators.
We compared the gene expression changes in Miz-1
KD cells to those in Myc KD ES cells (Figure 6C). We
found that 44 genes that are downregulated in Miz-1
KD human ES cells (29% of all genes downregulated in
Miz-1 KD) are also upregulated with Myc KD in ES
cells (P value = 0), suggesting a strong functional antag-
onism between Myc and Miz-1. The GO analysis
revealed enrichment among these antagonistically regu-
lated genes in Hox and developmental genes as well as
in regulators of apoptosis. These results suggest that
whereas the Myc/Miz-1 complex is likely to be responsi-
ble for the repression of developmental genes, Miz-1 is
needed for activation of those genes. The lack of differ-
entiation-associated phenotypic changes in Miz-1 KD
human ES cells thus is likely due to the absence of Miz-
1 that is required for the initiation of the differentiation
program. The overlap between those genes indepen-
dently upregulated in both the Myc KD and Miz-1 KD
ES cells was not statistically significant (P value = 0.54).
Interestingly, there are 57 genes that are upregulated in
Miz-1 KD and downregulated in Myc KD human ES
cells (P value = 0.0017), suggesting that in some con-
texts that Miz-1 may interfere with Myc transactivation,
again supporting the notion of Myc and Miz-1 as
antagonists. Importantly, only two genes were downre-
gulated in both Myc KD and Miz-1 KD cells (P value =
0.22), suggesting that Myc and Miz-1 do not synergisti-
cally activate transcription of target genes.
Myc interacts with Miz-1 and recruits Dnmt3a and HDACs
What is the mechanism by which Myc and Miz-1 act on
transcription? The Myc/Miz-1 complex recruits Dnmt3a
and HDACs to some target genes in immortalized cell
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Page 8 of 14lines [10,11]. To test whether Myc interacts with Miz-1,
Dnmt3a and HDACs in human ES cells, we carried out
coimmunoprecipitation (CoIP) with anti-c-Myc antibody
followed by Western blot analysis of the endogenous Myc
complexes in human ES cells. Our results indicated that
endogenous c-Myc coprecipitates with Miz-1, HDAC1,
HDAC2, and possibly HDAC3, as well as Dnmt3a [see
Figure S4A in Additional file 5]. Myc did not interact with
endogenous TRIM28, which was used as a negative con-
trol. These results indicate that Myc associates with sev-
eral components of repression complexes in human ES
cells. In addition to CoIP studies, we carried out ChIP
assays using anti-HDAC antibodies, which revealed
enrichment of HDACs on a significant subset of Miz-1/
Myc target genes [see Figure S4B in Additional file 5].
Discussion
Our functional genomics studies demonstrate that the
coordinate functions of Myc and Miz-1 go well beyond
the regulation of the limited set of genes previously
identified by a candidate target gene approach. Myc/
Miz-1 function involves a much broader set of targets
involved in the maintenance of ES cell biology and more
specifically in ES cell differentiation. Our findings also
implicate Hox genes as key Myc target genes. Hox genes
are repressed by Polycomb group proteins, which cata-
lyze methylation at histone H3 lysine 27 (H3K27me3) of
Hox genes to promote their repression in human ES
cells [36]. Differentiation of ES cells leads to erasure of
H3K27me3 marks and upregulation of Hox gene expres-
sion [37]. In our study we found that Hox gene expres-
sion is also repressed by the Myc/Miz-1 complex, which
represents a novel mechanism of Hox gene repression in
stem cells. The Hox genes targeted by Myc and Miz-1
possessed enrichment for H 3 K 2 7 m e 3m a r k sa sw e l l ,
suggesting a potential link between Myc and Polycomb
as has been observed in Drosophila [38].
Recent studies in mouse ES cells defined three func-
tionally separate ES modules: Core (74 genes), Polycomb
(449 genes), and Myc (355 genes) [39] suggesting that
Myc largely functions independently of Polycomb. We
found that out of 4,398 Myc target genes identified in
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Page 9 of 14our study in human ES cells, 862 genes (20%) are also
identified as Myc target genes in the study by Kim et al.
in mouse ES cells. We have identified 119 Myc target
genes that fell into the Polycomb module, 84 target
genes that fell into Myc module and 13 target genes
belonging to the Core module. The enrichment of the
genes identified as belonging to the Polycomb module
in identified Myc target genes in our study further sug-
gest the potential link between Myc and Polycomb in
human ES cells. An additional study [40] found that
Myc exhibits substantial overlap in genomic binding in
mouse ES cells with Polycomb binding, but Myc acti-
vated those Polycomb-targeted genes and had no effect
on H3K27me3 levels. These findings and our data here
leave open the precise role, if any, of Myc together with
Polycomb in ES cells, but at least suggest that Myc and
Polycomb are cooperative in ES cells, most likely not
through regulating H3K27me3.
We found evidence of a complex relationship between
Myc and cell survival in ES cells. The link between Myc
and apoptosis is well documented [41]. While Myc over-
expression is linked to cell death in some contexts, so is
the loss of Myc in other contexts [42]. Our ChIP-chip
study demonstrates that Myc directly controls the
expression of a large number of cell death related genes.
The absence of Myc, however, also leads to the activa-
tion of proapoptotic program, which can be attributed
to the global dysregulation of a variety of cellular path-
ways that in turn elicits secondary response involving
activation of a cell death program.
Our findings on localization of Miz-1 genomic binding
almost exclusively away from TSS were particularly
unexpected and of interest because the predominant
model in the field is that Miz-1 exclusively targets INR
sequences in the immediate proximity of TSS [1,43].
However, these previous studies only examined core
promoter regions of a few known candidate Miz-1 target
genes, likely not fully representing the global distribu-
tion of Miz-1 genomic binding and function.
What might be the mechanism underlying the Miz-1
INR-independent function? One possibility is that Miz-1
is recruited to the upstream promoter region through
interaction with other DNA-binding proteins. Alterna-
tively, Miz-1 may directly bind as yet unknown motifs
that are distinct from INRs in terms of both location
and sequence. We were not able to identify any novel
predicted consensus motifs for Miz-1 binding within
Myc and Miz-1 cobound regions by MEME algorithms,
but this may reflect the expected large size and com-
plexity of Miz-1 DNA binding sites as it has 13 zinc fin-
ger DNA binding domains. Since we did not find Myc
E-boxes significantly enriched in Myc/Miz-1 cobound
sequences, it remains unclear if Myc binds DNA directly
in such complexes.
More generally, we found two main types of Miz-1
genomic targets in human ES cells: (1) targets of puta-
tive Miz-1 activation that are associated strongly with
euchromatic, transcriptionally active histone marks, and
(2) targets of possible Miz-1 repression that lack or have
very low relative levels of euchromatic marks. The pool
of former, active genomic domains bound by Miz-1
comprises genes involved in regulation of metabolism,
cell cycle control, chromatin and protein ubiquitination,
indicating potential mechanisms by which Miz-1 regu-
lates ES cell biology in a Myc-independent manner. A
relatively small group of Miz-1 target genes (36 genes
out of 734 genes) displayed simultaneous enrichment in
activating and silencing histone modifications, including
several developmentally regulated genes such as MEIS2,
PAX6, GSC and SHOX2. These genes might be poised,
having ‘bivalent domains’, which harbor both activation
and silencing marks [44]. Myc binding to a subset of
genes within ‘bivalent domains’ was previously reported
[45,46], but here we implicate Miz-1 in this process.
Another model is that Myc and Miz-1 are strictly
antagonistic. Consistent with this model, Myc loss-of-
function in human ES cells leads to increased expression
of many Myc/Miz-1 targets. Interestingly, Myc and Miz-
1 may also be antagonistic in another, novel way in the
context of Myc activation. We found a statistically very
significant group of Myc targets of activation that were
not only downregulated by loss of Myc, but also upregu-
lated by loss of Miz-1. If Miz-1 indeed functions to
antagonize transactivation by Myc of a specific subset of
target genes, it must be through an as yet new mechan-
ism of action by Miz-1 as it has not been previously
reported to repress transcription or recruit corepressors.
The lack of a statistically significant population of genes
that are either downregulated in both Myc and Miz-1
KD, or upregulated in both KDs, clearly demonstrates
that Myc and Miz-1 do not act synergistically to either
activate or repress the expression of their target genes.
This further supports the model of Myc and Miz-1 gen-
erally being antagonists.
Conclusions
In the present work, we have provided important insight
into the mechanisms by which Myc represses differentia-
tion genes to promote pluripotency: a previously unknown
role of the Myc/Miz-1 complex in repression of differen-
tiation-related genes in human ES cells. We propose a
model whereby the Myc/Miz-1 pathway acts as a master
switch that represses multiple differentiation related genes
(Figure 7). In this model we hypothesize that Myc expres-
sion counteracts Miz-1 transactivation of Hox and other
differentiation-promoting genes thus maintaining ES cell
pluripotency. In the presence of prodifferentiation signals,
Myc levels are decreased, which leads to activation of Miz-
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Page 10 of 141 bound differentiation genes and results in initiation of
coordinated differentiation program. A clearer under-
standing of the potential roles of the Myc/Miz-1 complex
in tumorigenesis and iPS cell formation awaits future stu-
dies including functional genomics analyses of endogenous
Miz-1 and Myc in other cell types.
Methods
Cell culture
The human ES cell line H9 was maintained in ES med-
ium on irradiated mouse embryonic fibroblasts (Global
Stem, Rockville, MD). Cells were passaged by treatment
with 1 mg/ml collagenase (Gibco, Carlsbad, CA).
Chromatin immunoprecipitation and ChIP-chip
ChIPs were conducted on H9 human ES cells as pre-
viously described [47]. Then, 3 μgo fo n eo ft h ef o l l o w -
ing antibodies was added to each diluted fraction: anti-
N - M y c( S a n t aC r u zs c 5 3 9 9 3 ,S a n t aC r u z ,C A ) ,a n t i - c -
Myc (Abcam ab17355, San Francisco, CA), anti-AcH3K9
(Upstate 06-942, Billerica, MA), anti-H3K4me3 (Upstate
04-745, Billerica, MA), anti-HDAC 1 (Abcam ab31263,
San Francisco, CA), anti-HDAC 2 (Abcam ab12169, San
Francisco, CA), anti-HDAC 3 (Abcam ab7030, San Fran-
cisco, CA), anti-Miz-1 (Santa Cruz, sc-22837, Santa
Cruz, CA) or rabbit IgG or mouse IgG. We validated
that N-Myc and c-Myc antibodies were not crossreac-
tive. For Myc and Miz-1 ChIP-chip experiments, peaks
with the score ≥ 1a n dF D R≤ 0.05 were considered
positive targets for protein binding. For AcH3K9 and
H3K4me4 ChIP-chip experiments, peaks with the score
≥ 2, FDR ≤ 0.05 were considered positive targets for
protein binding.
Coimmunoprecipitation and western blot analysis
Cells were lysed in lysis buffer (50 mM 4-(2-hydro-
xyethyl)-1-piperazineethanesulfonic acid (Hepes) pH 7.9,
1m MM g C l 2, 20 mM NaCl, 10 mM ethylenediaminete-
tra-acetic acid (EDTA) pH 8.0, 10% glycerol, 0.2% nonyl
phenoxypolyethoxylethanol (NP-40), 1 × protease inhibi-
tor cocktail). Whole-cell lysates were subjected to
immunoprecipitation using the anti-c-Myc antibody
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Figure 7 Model. Myc/Miz-1 pathway acts as a master switch that represses multiple differentiation-associated genes.
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Page 11 of 14(Abcam, San Francisco, CA) overnight. Immunocom-
plexes were recovered with protein-G-sepharose beads
(GE Healthcare, Piscataway, NJ). Samples were resolved
by SDS-PAGE before transfer to polyvinylidene fluoride
(PVDF) membrane. The membranes were incubated
with the appropriate antibodies.
RNA interference
293T cells were transfected with the pLKO.1 lentiviral
constructs containing the shRNAs against human c-Myc
and N-Myc (Sigma Aldrich, St. Luis, MO) along with
the packaging plasmids (pMD.G and Delta 8.9), using
FuGene HD (Roche, Indianapolis, IN). Empty pLKO.1
construct was used as a control. For Miz-1 knockdown
experiments, platA packaging cells (Cell Biolabs, Inc,
San Diego, CA) were transduced with pRFP-C-RS vec-
tors containing either scrambled shRNA or shRNA spe-
cific to Miz-1. Supernatants containing the viruses were
harvested 48 h and 72 h after transfection. Human ES
cells H9 were infected with the viral supernatants in the
presence of 6 μg/ml of polybrene and selected with 1
μg/ml puromycin 48 h later.
qPCR and gene expression array analysis
Total RNA was isolated from human ES cells using the
RNeasy Plus mini kit (Qiagen, Valencia, CA) as
described by manufacturer. RNA was reverse transcribed
by using Superscript III First strand synthesis Supermix
(Invitrogen, Carlsbad, CA). qPCR assays were performed
in triplicate using Absolute Blue qPCR SYBR Green Mix
(Fisher Scientific, Pittsburgh, PA), except for Myc assays,
which were performed using TaqMan gene expression
assays (Applied Biosystems, Foster City, CA) on a Roche
LightCycler 480 (Indianapolis, IN). Expression was nor-
malized using peptidylprolyl isomerase A (PPIA; cyclo-
philin A) endogenous control. Sample data was analyzed
using comparative Ct method and standard deviation
calculated based on Applied Biosystems methods (Bulle-
tin 04371095).
For gene expression analysis, isolated RNA (40 ng/μl)
from Myc KD, Miz-1 KD and control ES cells was sub-
mitted to the UC Davis Expression Analysis Core for
gene expression analysis using Illumina Centrix Human-
6 Beadchip, San Diego, CA. Average normalization was
applied to the expression data from the three biological
replicates. Genes whose expression changed by at least
1.5-fold and a P value < 0.05 were considered differen-
tially expressed. For Miz-1 knockdown experiments,
genes whose expression changed by at least 1.3-fold and
a P value < 0.05 were considered differentially expressed.
Obtained results were analyzed with DAVID V6.7 Func-
tional Annotation Bioinformatics Microarray software.
In vitro differentiation to embryoid bodies (EBs)
Colonies of human ES cells were dislodged from plates
by treatment with 1 mg/ml of collagenase (Gibco, Carls-
bad, CA). Cells were washed and resuspended in differ-
entiation medium (Dulbecco’s modified Eagle medium
(DMEM) High Glucose (Invitrogen, Carlsbad, CA), 20%
fetal bovine serum (FBS) (Hyclone, Lakewood, NJ), 100
μM minimal essential medium (MEM) non-essential
amino acids (Invitrogen, Carlsbad, CA), 2 mM gluta-
mine (Invitrogen, Carlsbad, CA), and 100 μM b-mercap-
toethanol (Invitrogen, Carlsbad, CA). Resuspended cells
were plated in low-attachment 10 cm dishes. EBs were
collected for analysis 10 days later.
Additional material
Additional file 1: Tables S1 to S5. Table S1. Miz-1 direct targets. Table
S2. Myc direct targets. Table S3. Miz-1 and Myc targets. Table S4. Myc
knockdown gene expression changes. Table S5. Miz-1 knockdown gene
expression changes.
Additional file 2: Figure S1. Confirmation of Myc knockdown in human
embryonic stem (ES) cells by western blot analysis.
Additional file 3: Figure S2. Differentiation of human embryonic stem
(ES) cells into embryoid bodies (EBs) leads to a drastic reduction of levels
of Myc bound to Hox genes, and a significant upregulation of
differentiation-associated genes. (A) Chromatin immunoprecipitation
(ChIP) analysis of N-Myc and Miz-1 binding in human ES cells and EBs.
(B, C) Real-time quantitative real-time (qRT)-PCR PCR of a series of
differentiation-associated genes.
Additional file 4: Figure S3. Confirmation of Miz-1 knockdown (KD) in
human embryonic stem (ES) cells. (A) Western blot analysis of Miz-1
protein levels. (B) Phase contrast images of human ES cells transduced
with either scrambled small hairpin (sh)RNA control or shRNA specific to
Miz-1. Images were taken at 4 × magnification.
Additional file 5: Figure S4. Myc associates with Miz-1, HDACs, and
DNMT3A in vivo in human embryonic stem (ES) cells. (A)
Coimmunoprecipitation with a c-myc antibody or a non-specific IgG.
Western blot analysis was performed using antibodies specific to Miz-1,
Dnmt3a, HDAC1, HDAC2, and HDAC3. TRIM28 was used as a negative
control for the interaction with Myc. (B) Chromatin immunoprecipitation
(ChIP) on Myc and Miz-1 cobound gene targets.
Acknowledgements
We thank Vince Buffalo for advice on statistical analysis and Bonnie
Barrilleaux for a critical reading of the manuscript. This work was supported
by CIRM grant RN2-00922-1 (PK).
Author details
1Department of Cell Biology and Human Anatomy, University of California
Davis School of Medicine, Sacramento, CA, USA.
2Genome Center, University
of California Davis School of Medicine, Sacramento, CA, USA.
3Institute of
Pediatric Regenerative Medicine, Shriners Hospital For Children Northern
California, Sacramento, CA, USA.
4Department of Molecular and Cell Biology,
University of California Davis School of Medicine, Sacramento, CA, USA.
Authors’ contributions
PK and NV conceived the studies and the experimental design. NV
conducted most of the experiments with RC performing the ChIP-chip work.
KB and IK conducted some of the statistical analysis. NV and PK performed
the data analysis and wrote the manuscript. All authors read and approved
the manuscript.
Varlakhanova et al. Epigenetics & Chromatin 2011, 4:20
http://www.epigeneticsandchromatin.com/content/4/1/20
Page 12 of 14Competing interests
The authors declare that they have no competing interests.
Received: 10 August 2011 Accepted: 4 November 2011
Published: 4 November 2011
References
1. Peukert K, Staller P, Schneider A, Carmichael G, Hanel F, Eilers M: An
alternative pathway for gene regulation by Myc. EMBO J 1997,
16:5672-5686.
2. Gartel AL, Shchors K: Mechanisms of c-myc-mediated transcriptional
repression of growth arrest genes. Exp Cell Res 2003, 283:17-21.
3. Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H, Möröy T,
Bartek J, Massague J, Hänel F, Eilers M: Repression of p15
INK4b expression
by Myc through association with Miz-1. Nat Cell Biol 2001, 3:392-399.
4. Wanzel M, Russ AC, Kleine-Kohlbrecher D, Colombo E, Pelicci P-G, Eilers M:
A ribosomal protein L23-nucleophosmin circuit coordinates Miz1
function with cell growth. Nat Cell Biol 2008, 10:1051-1061.
5. Seoane J, Le HV, Massague J: Myc suppression of the p21(Cip1) Cdk
inhibitor influences the outcome of the p53 response to DNA damage.
Nature 2002, 419:729-734.
6. Yang BS, Gilbert JD, Freytag SO: Overexpression of Myc suppresses CCAAT
transcription factor/nuclear factor 1-dependent promoters in vivo. Mol
Cell Biol 1993, 13:3093-3102.
7. Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R: BCL6 interacts with the
transcription factor Miz-1 to suppress the cyclin-dependent kinase
inhibitor p21 and cell cycle arrest in germinal center B cells. Nat
Immunol 2005, 6:1054-1060.
8. Weber A, Marquardt J, Elzi D, Forster N, Starke S, Glaum A, Yamada D,
Defossez PA, Delrow J, Eisenman RN, Christiansen H, Eilers M: Zbtb4
represses transcription of P21CIP1 and controls the cellular response to
p53 activation. EMBO J 2008, 27:1563-1574.
9. Liu Q, Basu S, Qiu Y, Tang F, Dong F: A role of Miz-1 in Gfi-1-mediated
transcriptional repression of CDKN1A. Oncogene 29:2843-2852.
10. Brenner C, Deplus R, Didelot C, Loriot A, Viré E, De Smet C, Gutierrez A,
Danovi D, Bernard D, Boon T, Pelicci PG, Amati B, Kouzarides T, de
Launoit Y, Di Croce L, Fuks F: Myc represses transcription through
recruitment of DNA methyltransferase corepressor. EMBO J 2005,
24:336-346.
11. Kurland JF, Tansey WP: Myc-mediated transcriptional repression by
recruitment of histone deacetylase. Cancer Res 2008, 68:3624-3629.
12. Collins S, Groudine M: Amplification of endogenous myc-related DNA
sequences in a human myeloid leukaemia cell line. Nature 1982, 298:679-681.
13. Meyer N, Penn LZ: Reflecting on 25 years with MYC. Nat Rev Cancer 2008,
8:976-990.
14. Amati B, Frank SR, Donjerkovic D, Taubert S: Function of the c-Myc
oncoprotein in chromatin remodeling and trasncription. Biochim Biophys
Acta 2001, 1471:M135-M145.
15. Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H: Oncogenic
activity of the c-Myc protein requires dimerization with Max. Cell 1993,
72:233-245.
16. Patel JH, Loboda AP, Showe MK, Showe LC, McMahon SB: Analysis of
genomic targets reveals complex functions of MYC. Nat Rev Cancer 2004,
4:562.
17. McMahon SB, Wood MA, Cole MD: The essential cofactor TRRAP recruits
the histone acetyltransferase hGCN5 to c-Myc. Mol Cell Biol 2000,
20:556-562.
18. Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, Chan HM,
Livingston DM, Amati B: MYC recruits the TIP60 histone acetyltransferase
complex to chromatin. EMBO Rep 2003, 4:575-580.
19. Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB, Sharp PA,
Young RA: c-Myc regulates transcriptional pause release. Cell 2010,
141:432-445.
20. Eberhardy SR, Farnham PJ: Myc recruits P-TEFb to mediate the final step
in the transcriptional activation of the cad promoter. J Biol Chem 2002,
277:40156-40162.
21. Gebhardt A, Frye M, Herold S, Benitah SA, Braun K, Samans B, Watt FM,
Elsasser HP, Eilers M: Myc regulates keratinocyte adhesion and
differentiation via complex formation with Miz1. J Cell Biol 2006,
172:139-149.
22. Kerosuo L, Piltti K, Fox H, Angers-Loustau A, Hayry V, Eilers M, Sariola H,
Wartiovaara K: Myc increases self-renewal in neural progenitor cells
through Miz-1. J Cell Sci 2008, 121:3941-3950.
23. Freytag SO, Geddes TJ: Reciprocal regulation of adipogenesis by Myc and
C/EBP alpha. Science 1992, 256:379-382.
24. Kime L, Wright SC: Mad4 is regulated by a transcriptional repressor
complex that contains Miz-1 and c-Myc. Biochem J 2003, 370:291-298.
25. Sridharan R, Tchieu J, Mason MJ, Yachechko R, Kuoy E, Horvath S, Zhou Q,
Plath K: Role of the murine reprogramming factors in the induction of
pluripotency. Cell 2009, 136:364-377.
26. Smith KN, Singh AM, Dalton S: Myc represses primitive endoderm
differentiation in pluripotent stem cells. Cell Stem Cell 2010, 7:343-354.
27. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K,
Yamanaka S: Induction of pluripotent stem cells from adult human
fibroblasts by defined factors. Cell 2007.
28. Varlakhanova NV, Cotterman RF, deVries WN, Morgan J, Donahue LR,
Murray S, Knowles BB, Knoepfler PS: myc maintains embryonic stem cell
pluripotency and self-renewal. Differentiation 2010, 80:9-19.
29. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S: LIF/STAT3
controls ES cell self-renewal and pluripotency by a Myc-dependent
mechanism. Development 2005, 132:885-896.
30. Adhikary S, Peukert K, Karsunky H, Beuger V, Lutz W, Elsasser HP, Moroy T,
Eilers M: Miz1 is required for early embryonic development during
gastrulation. Mol Cell Biol 2003, 23:7648-7657.
31. Iraci N, Diolaiti D, Papa A, Porro A, Valli E, Gherardi S, Herold S, Eilers M,
Bernardoni R, Della Valle G, Perini G: A SP1/MIZ1/MYCN repression
complex recruits HDAC1 at the TRKA and p75NTR promoters and affects
neuroblastoma malignancy by inhibiting the cell response to NGF.
Cancer Res 71:404-412.
32. Pan G, Tian S, Nie J, Yang C, Ruotti V, Wei H, Jonsdottir GA, Stewart R,
Thomson JA: Whole-genome analysis of histone H3 lysine 4 and lysine
27 methylation in human embryonic stem cells. Cell Stem Cell 2007,
1:299-312.
33. Bieda M, Xu X, Singer MA, Green R, Farnham PJ: Unbiased location
analysis of E2F1-binding sites suggests a widespread role for E2F1 in
the human genome. Genome Res 2006, 16:595-605.
34. Bailey TL, Williams N, Misleh C, Li WW: MEME: discovering and analyzing
DNA and protein sequence motifs. Nucleic Acids Res 2006, 34:W369-373.
35. Ji X, Li W, Song J, Wei L, Liu XS: CEAS: cis-regulatory element annotation
system. Nucleic Acids Res 2006, 34:W551-554.
36. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM,
Chevalier B, Johnstone SE, Cole MF, Isono K, Koseki H, Fuchikami T, Abe K,
Murray HL, Zucker JP, Yuan B, Bell GW, Herbolsheimer E, Hannett NM,
Sun K, Odom DT, Otte AP, Volkert TL, Bartel DP, Melton DA, Gifford DK,
Jaenisch R, Young RA: Control of developmental regulators by Polycomb
in human embryonic stem cells. Cell 2006, 125:301-313.
37. Kashyap V, Gudas LJ, Brenet F, Funk P, Viale A, Scandura JM: Epigenomic
reorganization of the clustered Hox genes in embryonic stem cells
induced by retinoic acid. J Biol Chem 2011, 286:3250-3260.
38. Goodliffe JM, Wieschaus E, Cole MD: Polycomb mediates Myc
autorepression and its transcriptional control of many loci in Drosophila.
Genes Dev 2005, 19:2941-2946.
39. Kim J, Woo AJ, Chu J, Snow JW, Fujiwara Y, Kim CG, Cantor AB, Orkin SH: A
Myc network accounts for similarities between embryonic stem and
cancer cell transcription programs. Cell 2010, 143:313-324.
40. Lin CH, Lin C, Tanaka H, Fero ML, Eisenman RN: Gene regulation and
epigenetic remodeling in murine embryonic stem cells by c-Myc. PLoS
One 2009, 4:e7839.
41. Hoffman B, Liebermann DA: Apoptotic signaling by c-MYC. Oncogene
2008, 27:6462-6472.
42. Laurenti E, Varnum-Finney B, Wilson A, Ferrero I, Blanco-Bose WE,
Ehninger A, Knoepfler PS, Cheng PF, MacDonald HR, Eisenman RN,
Bernstein ID, Trumpp A: Hematopoietic stem cell function and survival
depend on c-Myc and N-Myc activity. Cell Stem Cell 2008, 3:611-624.
43. Gartel AL, Ye X, Goufman E, Shianov P, Hay N, Najmabadi F, Tyner AL: Myc
represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.
Proc Natl Acad Sci USA 2001, 98:4510-4515.
44. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B,
Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL,
Lander ES: A bivalent chromatin structure marks key developmental
genes in embryonic stem cells. Cell 2006, 125:315-326.
Varlakhanova et al. Epigenetics & Chromatin 2011, 4:20
http://www.epigeneticsandchromatin.com/content/4/1/20
Page 13 of 1445. Guccione E, Martinato F, Finocchiaro G, Luzi L, Tizzoni L, Dall’ Olio V,
Zardo G, Nervi C, Bernard L, Amati B: Myc-binding-site recognition in the
human genome is determined by chromatin context. Nat Cell Biol 2006,
8:764-770.
46. Schilling G, Bruweleit M, Harbeck N, Thomssen C, Becker K, Hoffmann R,
Villena C, Schutte M, Hossfeld DK, Bokemeyer C, de Wit M: Phase II trial of
vinorelbine and trastuzumab in patients with HER2-positive metastatic
breast cancer. A prospective, open label, non-controlled, multicenter
phase II trial (to investigate efficacy and safety of this combination
chemotherapy). Invest New Drugs 2009, 27:166-172.
47. Cotterman R, Jin VX, Krig SR, Lemen JM, Wey A, Farnham PJ, Knoepfler PS:
N-Myc regulates a widespread euchromatic program in the human
genome partially independent of its role as a classical transcription
factor. Cancer Res 2008, 68:9654-9662.
doi:10.1186/1756-8935-4-20
Cite this article as: Varlakhanova et al.: Myc and Miz-1 have coordinate
genomic functions including targeting Hox genes in human embryonic
stem cells. Epigenetics & Chromatin 2011 4:20.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Varlakhanova et al. Epigenetics & Chromatin 2011, 4:20
http://www.epigeneticsandchromatin.com/content/4/1/20
Page 14 of 14